# A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.

> **NCT00425438** · PHASE3 · TERMINATED · sponsor: **Hoffmann-La Roche** · enrollment: 52 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Mycophenolate Mofetil
- **DRUG:** Corticosteroids
- **DRUG:** Azathioprine
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT00425438
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** Study was terminated early for administrative reasons.
- **Last updated:** 2014-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00425438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00425438, "A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00425438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*